trial
as of 2026-07-01Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
NCTId NCT02526030
at a glance
Phase 4 · Completed
Enrollment 203 (actual)
Sponsored by Fundación Marques de Valdecilla
Primary completion 2014-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
203 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2008-10
Primary completion
2014-02
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Fundación Marques de ValdecillaLead Sponsor
Instituto de Investigación Marqués de ValdecillaCollaborator
Investigators
1
Benedicto Crespo-Facorro, ProfessorPrincipal Investigator
Sites
1 total
Santander, Spain
Facts & assertions
4 sourced
Enrollment
203
Phase
PHASE4
Primary Completion Date
2014-02
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator